Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived
from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of …

Simple Summary Several factors, both patient-and disease-related, are essential to
accurately estimate acute myeloid leukemia (AML) prognosis. The rapidly evolving field …

Patients with secondary acute myeloid leukemia (AML) often escape inclusion in clinical
trials and thus, population‐based studies are crucial for its accurate characterization. In this …

Older patients with newly diagnosed acute myeloid leukemia (AML) in the phase 3 AZA-AML-
001 study were evaluated at entry for cytogenetic abnormalities, and a subgroup of patients …

Context.—A complete diagnosis of acute leukemia requires knowledge of clinical
information combined with morphologic evaluation, immunophenotyping and karyotype …

Abstract Background/Aim: As the knowledgebase of acute myeloid leukemia (AML) has
grown, classification systems have moved to incorporate these new findings. Methods: We …

Acute myeloid leukemia (AML) is a devastating disease, globally causing 85 000 deaths per
year in 2016, a number predicted to double in 2040, with years of life lost estimated to be 2.6 …

Large, comprehensive population-based studies in acute myeloid leukemia (AML) are
scarce. We conducted a nationwide population-based study on treatment, trial participation …

Myelodysplastic syndrome (MDS) is a clonal bone marrow disorder, typically of older adults,
which is characterized by ineffective hematopoiesis, peripheral blood cytopenias and risk of …

1 Grimwade D, Ivey A, Huntly BJ. Molecular landscape of acute myeloid leukemia in
younger adults and its clinical relevance. Blood 2016; 127: 29–42. 2 Xie M, Lu C, Wang J …